CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg)

CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg)

Product Description

CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg) is a premium research peptide formulation combining three well-known growth hormone secretagogues in a single vial. This advanced blend contains 3mg of CJC-1295 (Mod GRF 1-29), 3mg of Ipamorelin, and 3mg of GHRP-2, designed for laboratory and scientific research applications involving growth hormone signaling and endocrine function studies.

CJC-1295 (Mod GRF 1-29) is a modified Growth Hormone Releasing Hormone (GHRH) analog that has been studied for its ability to support natural pulsatile growth hormone release. Ipamorelin is a selective ghrelin receptor agonist investigated for stimulating growth hormone secretion with minimal impact on other hormones. GHRP-2 is a potent Growth Hormone Releasing Peptide (GHRP) commonly researched for its synergistic effects alongside GHRH analogs.

The combination of these three peptides is frequently utilized in research exploring growth hormone pathways, tissue regeneration, metabolic activity, recovery mechanisms, and cellular signaling. Each batch undergoes rigorous quality testing to ensure high purity and consistency for research purposes.

Product Specifications

• Product Name: CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend
• Strength: 9mg per vial
• Composition:
  • CJC-1295 (Mod GRF 1-29) – 3mg
  • Ipamorelin – 3mg
  • GHRP-2 – 3mg
• Purity: ≥99%
• Form: Lyophilized Powder
• Appearance: White to Off-White Powder
• Grade: Research Grade
• Storage: Store refrigerated at 2–8°C after reconstitution
• Testing: HPLC & Mass Spectrometry Verified
• Country of Origin: USA